Cannabis inflorescence, Cannabis spp. Standards of identity, analysis, and quality control. Upton, Roy, et al.
American Herbal Pharmacopoeia. 2013 Dec, (see separate binder).
Impact of ADHD and cannabis use on executive functioning in young adults. Tamm, Leanne, et al.
Drug and Alcohol Dependence. 2013 December 1 133(2).
Cannabidivarin (CBDV) suppresses penthylenetretrazole (PTZ)-induced increases in epilepsy-related gene expression. Amada, Naoki, et al.
Peer Journal. 2013 Nov 21, 1: e214.
Marijuana use patterns among patients with inflammatory bowel disease. Ravikoff Allegretti, Jessica, et al.
Inflammatory Bowel Diseases. 2013 Dec, 19(13): 2809-2814.
Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules. Scott, K A, et al.
Anticancer Research. 2013 Oct, 33(10): 4373-4380 (abstract).
Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat. Calik, M W, et al.
Respiratory Physiology & Neurobiology. 2013 Oct, 190: 20-24.
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes. Stanley, C P, et al.
European Journal of Pharmacology. 2013 Oct 8, 720(1-3): 376-382 (abstract).
Sub-types of attention deficit-hyperactivity disorder (ADHD) and cannabis use. Loflin, M, et al.
Substance Use & Misuse. 2013 Oct 4, 49(4): 427-434 (abstract).
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy. Ward, S J, et al.
British Journal of Pharmacology. 2014 Feb, 171(3): 636-645.
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Cooper, Z D, et al.
Neuropsychopharmacology. 2013 Sep, 38(10): 1984-1992.
Why pot makes you feel good. Cholewa, K M, et al.
AlterNet.org. 2013 Aug 18, online article.
The endocannabinoid system and emotional processing: a pharmacological fMRI study with Δ9-tetrahydrocannabinol. Bossong, Matthijs G, et al.
European Neuropsychopharmacology. 2013 Dec, 23(12): 1687-1697.
The medicinal use of cannabis and cannabinoids – an international cross-sectional survey on administration forms. Hazekamp, A, et al.
Journal of Psychoactive Drugs. 2013 Jul-Aug, 45(3): 199-210 (abstract).
Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C co-infection: a longitudinal cohort analysis. Brunet, Laurence, et al.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2013 Sep 1, 57(5): 663-670.
Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Morgan, C J, et al.
Addiction Behaviors. 2013 Sep, 38(9): 2433-2436 (abstract).
The medical necessity for medicinal cannabis: prospective, observational study evaluating the treatment in cancer patients supportive for palliative care. Bar-Sela, Gil, et al.
Evidence-based Complementary and Alternative Medicine. 2013, e510392.
An ultra-low dose of tetrahydrocannabinol provides cardioprotection. Waldman, M, et al.
Biochemical Pharmacology. 2013 Jun 1, 85(11): 1626-1633 (abstract).
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. Wargent, E T, et al.
Nutrition and Diabetes. 2013 May 27, 3, e68.
Elevated brain cannabinoid CB1 receptor availability in posttraumatic stress disorder: a positron emission tomography study. Neumeister, Alexander, et al.
Molecular Psychiatry. 2013 Sep, 18(9): 1034-1040.
Talking terpenes. Lee, Martin, A
High Times. May 2013.
THC can prevent brain damage – study. Science 2.0, 2013 May 30.
Effects of marijuana smoking on the lung. Tashkin, Donald P
Annals of the American Thoracic Society. 2013 Jun, 10(3): 239-247.
Low-dose vaporized cannabis significantly improves neuropathic pain. Wilsey, B, et al.
Journal of Pain. 2013 Feb, 14(2): 136-148.
High on health: cannabinoids in the food supply. Badiner, Alan
www.wakingtimes.com. 2013 Apr 25.
Comparison of the analgesic effects of Dronabinol and smoked marijuana in daily marijuana smokers. Cooper, Z D, et al.
Neuropsychopharmacology. 2013 Sep, 38(10): 1984-1992.
Cannabinergic pain medicine: a concise primer and survey of randomized-controlled trial results. Aggarwal, S K
Clinical Journal of Pain. 2013, Feb 29(2): 162-171 (abstract).
Low dose vaporized cannabis significantly improves neuropathic pain. Wilsey, Barth, et al.
Journal of Pain. 2013 Feb 14(2): 136-148.
Information for health care professionals. Cannabis (marihuana, marijuana) and cannabinoids. Health Canada. February 2013 (see separate binder).
Marijuana: a primer. Armentano, Paul
NORML. 29 Jan 2013.
Risk of road-accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies. Elvik, R
Accident Analysis and Prevention. 2013 Nov. 60:254-267 (abstract).
Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study. Naftali, Timna, et al.
Clinical Gastroenterology and Hepatology. 2013 Oct, 11(10): 1276-1280 (abstract).
Role of cannabinoids in pain management. Russo, Ethan B, et al.
Comprehensive treatment of chronic pain by medical, interventional and integrative approaches. Deer, T.R., et al. (eds.), American Academy of Pain Medicine 2013 181-197.
Pregnancy, breast feeding, and marijuana: a review article. Hill, Meg, et al.
Obstetrical And Gynecological Survey. 2013 68(10): 710-718.
The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Penner, Elizabeth A, et al.
The American Journal of Medicine. 2013 126(7): 583-589.
Modulating the endocannabinoid system in human health and disease: successes and failures. Pacher, Pál, et al.
Federation of European Biochemical Societies (FEBS) Journal. 2013 280(9): 1918-1943.
Marijuana: current concepts. Greydanus, Donald E, et al.
Frontiers in Public Health 2013 October Article 42.